U.S. Markets open in 33 hrs, 33 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,464.40 | 30.69 | 0.29% |
| NASDAQ | 2,176.05 | 6.87 | 0.32% |
| S&P 500 | 1,110.63 | 4.98 | 0.45% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 58.99 09:39 AM EST | |
|---|---|---|
| Day High | 60.06 10:05 AM EST |
|
| Range | 1.07 |
| Volume | 769,554 | |
|---|---|---|
| 30-Day Avg Vol | 956,000 |
|
| Difference | -19.50% |
| Market Cap | 11.12 B | |
|---|---|---|
| Mkt Cap Chg | 153.35 M |
| Shares Out | 187.01 M | |
|---|---|---|
| % Shrs Traded | 0.41% | |
| 1yr EPS Est | 2.962 |
| 52-Wk Low | 31.66 | |
|---|---|---|
| 52-Wk High | 60.32 |
|
| Range | 28.66 |
| Prev Close | 58.67 11/24/09 | |
|---|---|---|
| Today's Open | 59.17 | |
| Change | 0.85% |
| Dividend (TTM) | 0.29724 | |
|---|---|---|
| Div Yield (TTM) | 0.53% | |
| Ex-Div Date | 09/09/2009 | |
| Div Date | 10/08/2009 |
|
| Short Interest | 2.74 M |
| Revenue (LFY) | 3.02 B | |
|---|---|---|
| Earnings (LFY) | 156.00 M | |
| Earnings (MRQ) | 43.50 M | |
| Next Earn Est | 0.594 | |
| Next Earnings |
|
|
| EPS (TTM) | -0.14896 | |
| 1yr EPS Growth | -12.37% |
| P/E Ratio (TTM) | 21.79 | |
|---|---|---|
| P/E Ratio (Fwd) | 20.00 | |
| PEG Ratio | 2.20 | |
| Return on Equity | 5.09 | |
| Beta | 0.96 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Shire's drugs help patients pay attention and stay on task. The specialty drug company, the UK's third largest, has a roster that includes attention deficit hyperactivity disorder (ADHD) treatments Vyvanse ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.594 N/A | — — |
—
—
|
| Last Quarter | 0.50 9/30/09 | 0.49 9/30/09 |
-0.01
Missed
|
| 2 Quarters Ago | 0.471 6/30/09 | 0.60 6/30/09 |
0.129
Beat
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 621.08 M | 3.02 B |
| Gross Profit | 492.17 M | 2.49 B |
| Operating Income | 39.35 M | 500.90 M |
| Net Income | 43.50 M | 156.00 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts